Literature DB >> 15704174

Smoking and non-Hodgkin lymphoma: case-control study in Italy.

Renato Talamini1, Jerry Polesel, Maurizio Montella, Luigino Dal Maso, Anna Crispo, Michele Spina, Silvia Franceschi, Marina Crovatto, Carlo La Vecchia.   

Abstract

Tobacco smoking is a well-documented risk factor for several cancers, but the role of cigarette smoking in the etiology of non-Hodgkin lymphoma (NHL) is inadequately understood. Hepatitis C virus (HCV) has been associated with NHL, but the interaction between HCV and smoking habits has not yet been studied. Between 1999 and 2002, we conducted a case-control study on the association of HCV, smoking habits and NHL in 2 areas of northern and southern Italy. Cases were 225 consecutive patients (median age, 59 years) with a new diagnosis of NHL that were admitted to reference and general hospitals. Controls were 504 patients (median age, 63 years) admitted to the same hospitals as cases, for a wide spectrum of acute, nonneoplastic, nonimmune-, nor tobacco-related conditions. Current, heavy smokers (> or = 20 cigarettes/day) had an odds ratio (OR) of NHL of 2.10 (95% confidence interval, CI: 1.07-4.12) compared to never smokers. The association between smoking and NHL was consistent across strata of sex and age. Compared to never smokers, current smokers of > or = 20 cigarettes/day had ORs of 1.14 (95% CI: 0.37-3.56) for B-cell-low-grade, 2.10 (95% CI: 0.94-4.67) for B-cell-intermediate and high-grade, and 25.84 (95% CI: 1.95-342.17) for T-cell NHL. The effect of tobacco smoking and HCV were independent on the relative risk, leading a 4-fold elevated risk in current smokers HCV positive subjects. Tobacco smoking and hepatitis C virus (HCV) have been associated to non-Hodgkin lymphoma (NHL), but the interaction between HCV and smoking habits has not yet been studied. Our study confirms that tobacco is related to NHL, and reports on the combined effect of tobacco smoking and HCV. Infection acted together according to a multiplicative model, leading to a 4-fold elevated risk in current smokers HCV positive subjects. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15704174     DOI: 10.1002/ijc.20891

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma.

Authors:  Brian C-H Chiu; Qing Lan; Bhavana J Dave; Aaron Blair; Shelia Hoar Zahm; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2008

2.  Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study.

Authors:  Yani Lu; Sophia S Wang; Peggy Reynolds; Ellen T Chang; Huiyan Ma; Jane Sullivan-Halley; Christina A Clarke; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2011-07-18       Impact factor: 4.897

3.  Geographic distribution of hematopoietic cancers in the Nile delta of Egypt.

Authors:  C M Herzog; S Dey; A Hablas; H M Khaled; I A Seifeldin; M Ramadan; H El-Hamzawy; M L Wilson; A S Soliman
Journal:  Ann Oncol       Date:  2012-05-02       Impact factor: 32.976

4.  Risk Factors of Follicular Lymphoma.

Authors:  Shuangge Ma
Journal:  Expert Opin Med Diagn       Date:  2012-05-08

5.  Hepatitis C virus infection and risk of cancer: a population-based cohort study.

Authors:  Lars Haukali Omland; Dora Körmendiné Farkas; Peter Jepsen; Niels Obel; Lars Pedersen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

6.  The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study.

Authors:  Martina Taborelli; Maurizio Montella; Massimo Libra; Rosamaria Tedeschi; Anna Crispo; Maria Grimaldi; Luigino Dal Maso; Diego Serraino; Jerry Polesel
Journal:  BMC Cancer       Date:  2017-06-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.